我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

内皮细胞特异性分子1预处理对小鼠骨髓间充质干细胞生物学特性的影响

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2013年第1期
页码:
22-027
栏目:
基础研究
出版日期:
2013-02-25

文章信息/Info

Title:
Empirical study of bionomical effect of mice mesenchymal stem cells preconditioned by endothelial cellspecific molecule1
作者:
朱宗成1; 惠 杰2; 沈振亚2; 盛晓东1; 周建龙1; 范韬1; 金骁琦1
(1.常熟市第二人民医院心内科，江苏 常熟 215500；2.苏州大学附属第一人民医院心内科，江苏 苏州 215006)
Author(s):
ZHU Zong cheng1;  HUI Jie2;  SHEN Zhenya2;  SHENG Xiaodong1;  ZHOU Jianlong1;  FAN Tao1;  JIN Xiaoqi1
(1.Department of Cardiology, Changshu Second People’s Hospital, Suzhou 215006, Jiangsu, China; 2.Department of Cardiology, First Hospital Affiliated to Suzhou University, Suzhou 215006, Jiangsu, China)
关键词:
内皮细胞特异性分子1; 骨髓间充质干细胞; 心肌梗死; 小鼠
Keywords:
endothelial cellspecific molecule1;  bone marrow mesenchymal stem cells;  myocardial infarction;  mouse
分类号:
R542.2
DOI:
-
文献标识码:
A
摘要:
目的:探讨内皮细胞特异性分子1（ESM1）孵育预处理对小鼠骨髓间充质干细胞生物学特性的影响，为干细胞移植提供实验依据。方法： 培养及鉴定骨髓间充质干细胞。提取细胞数及浓度固定的初级培养液中的骨髓间充质干细胞，并分为两组：对照组（不进行预处理）及3个浓度（005 μg/ml、01 μg/ml、015 μg/ml）的ESM1预处理组。每组设4个复孔，每孔均处理60 min。收集每孔中的条件培养液，检测预处理对骨髓间充质干细胞分泌血管内皮生长因子(VEGF)及碱性磷酸酶(ALP)的影响。结果： ESM1孵育预处理骨髓间充质干细胞后，其存活率明显增加，而凋亡率显著下降，且骨髓间充质干细胞增殖能力随着ESM1预处理浓度的增加而逐渐升高，凋亡率却呈相反的下降趋势。ESM1预处理后，骨髓间充质干细胞分泌VEGF、ALP的水平明显升高，且随着ESM1浓度的增加，骨髓间充质干细胞分泌VEGF、ALP的水平也相应增加。ESM1孵育预处理后的骨髓间充质干细胞，细胞形态一致，生长及分化速度加快。结论： ESM1孵育预处理骨髓间充质干细胞不仅促进骨髓间充质干细胞增殖及降低其凋亡，而且可增加VEGF、ALP的分泌。ESM1通过活化骨髓间充质干细胞，提高细胞本身的潜能，继而提高其存活、增殖的能力, 为临床急性心肌梗死的治疗提供了广泛的应用前景。
Abstract:
AIM:To investigate the endothelial cellspecific molecule1 (ESM1) after incubation with pretreatment on mouse bone marrow mesenchymal stem cells (BMMSCs). We studied the biological characteristic influence in order to provide an experimental basis for stem cell transplantation. METHODS: For cultivation and identification of BMMSCs, extraction of cell number and concentration of fixed primary cultured BMMSCs were divided into two groups: control group (no pretreatment) and three concentrations (005 μg/ml, 01 μg/ml, 015 μg/ml) of ESM1 pretreatment group. Each group has four complex holes. Each hole was preconditioned for 60 min. Every hole was collected in the conditioned medium, and effect of pretreatment on BMMSCs on secretion of vascular endothelial growth factor (VEGF) and alkaline phosphatase (ALP) was shown. RESULTS: After incubation of ESM1 preconditioned BMMSCs, the survival rate increased significantly, whereas apoptosis rate decreased significantly and proliferation of BMMSCs with increasing concentrations of ESM1 pretreatment increased, but the apoptosis rate showed the opposite decreasing trend. ESM1 after pretreatment showed BMMSCs secreted VEGF, ALP levels increased, and with increasing the concentration of ESM1, BMMSCs secreted VEGF. ALP levels also increased accordingly. Incubation of ESM1 preconditioned BMMSCs, cell morphology, and growth and differentiation is accelerated. CONCLUSION: ESM1 incubated with preconditioned BMMSCs promote the proliferation of BMMSCs and reduce apoptosis and can increase VEGF and ALP secretion. ESM1 through the activation of BMMSCs improves the cell potential itself and then improves survival and proliferation. The prospect exists for clinical treatment of acute myocardial infarction with wide application.

参考文献/References

[1]Lassalle P,Molet S,Janin A,et al.ESM1 is a novel human endothelial cell specific molecule expressed in lung and regulated by cytokines[J].J Biol Chem,1996,271(34):20458-20464.

[2]Bechard D,Scherpereel A,Hammad H,et al.Human endothelialcell specific molecule1 binds directly to the integrin CD11a/CD18(LFA 1)and blocks binding to intercellular adhesion molecule1[J].J Immunol,2001,167(6):3099-3106.

[3]Janke J,Engeli S,Gorzelniak K,et al.Adipose tissue and circulating endothelial cell specific molecule1 in human obesity[J].Horm Metab Res,2006, 38(1):28-33.

[4]Sarrazin S,Lyon M,Deakin JA,et al.Characterization and binding activity of th chondroitin/dermatan sulfate chain from Endocan, a soluble endothelial proteoglycan[J].Glycobiology,2010,20(11):1380-1388.

[5]Bechard D,Gentina T,Delehedde M,et al.Endocan is a novel chondroitin sulfate/dermatan sulfate proteoglycan that promotes hepatocyte growth factor/scatter factor mitogenic activity[J].J Biol Chem,2001,276(51):48341-48349.

[6]Rennel E,Mellberg S,Dimberg A,et al.Endocan is a VEGFA and PI3K regulated gene with increased expression in human renal cancer[J].Exp Cell Res,2007,313(7):1285-1294.

[7]Leroy X,Aubert S,Zini L,et al.Vascular endocan(ESM 1)is markedly overexpressed in clear cell renal cell carcinoma[J].Histopathology,2010,56(2):180-187.

[8]Bechard D,Meignin V,Scherpereel A,et al.2000 Characterization of the secreted form of endothelialcellspecific molecule 1 by specific monoclonal antibodies[J].J Vasc Res,2000,37:417-425.

[9]Grigoriu BD,Depontieu F,Scherpereel A,et al.Endocan expression and relationship with survival in human nonsmall cell lung cancer[J]. Clin Cancer Res,2006,12(15):4575-4582.

[10]uang GW,Tao YM,Ding X.Endocan expression correlated withpoor survival in human hepatocellular carcinoma[J].Dig Dis Sci,2009,54(2):389-394.

[11]Maurage CA,Adam E,Mineo JF,et al.Endocan expression and localization in human glioblastomas[J].J Neuropathol Exp Neurol,2009,68(6):633-641.

[12]赵卫林,李书亭,乔钦增,等. 太行山区三县一市胃癌危险因素的配对病例对照研究[J].中国民康医学,2006,18(13):554-555.

[13]Kahn J,Mehraban F,Ingle G,et al.Gene expression profiling in an in vitro modelofangiogenesis[J].Am J Pathol,2000,156(6):1887-1990.

[14]Bechard D,Meignin V,Scherpereel A,et al.Characterization of the secreted form of endothelialcellspecific molecule 1 by specific monoclonal antibodies[J].J Vasc Res,2000,37(5):417-425.

[15]Abid MR,Yi X,Yano K,et al.Vascular endocan is preferentially expressed in tumor endothelium[J].Microvasc Res,2006,72(3):136-145.

[16]Bechard D,Gentina T,Delehedde M,et al.Endocan is a novel chondroitin sulfate/dermatan sulfate proteoglycan that promotes hepatocyte growth factor/scatter factor mitogenic activity[J].J Biol Chem,2011,276(51):48341-48349.

[17]Bishop JR,Schuksz M,Esko JD.Heparan sulphate proteoglycans finetune mammalian physiology[J].Nature,2007,446(7139):1030-1037.

[18]Bechard D,Scherpereel A,Hammad H,et al.Human endothelialcell specific molecule1 binds directly to the integrin CD11a/CD18(LFA 1)and blocks binding to intercellular adhesion molecule1[J].J Immunol,2001,167(6):3099-3106.

[19]Depontieu F,Grigoriu BD,Scherpereel A,et al.Loss of Endocan tumorigenic properties after alternative splicing of exon 2[J].BMC Cancer,2008,8:14.

备注/Memo

备注/Memo:
收稿日期：2012-06-29.基金项目：常熟市科技局和卫生局项目资助（CS201015） 作者简介：朱宗成，住院医师，硕士Email:zongchengzhu@163.com
更新日期/Last Update: 2013-03-20